Milestone Pharmaceuticals Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $83.5M | $85.9M |
| FY2019 | $0 | $114.9M | $119.8M |
| FY2020 | — | $143.1M | $72.3M |
| FY2021 | — | $112.6M | $114.1M |
| FY2022 | — | $66.3M | $7.6M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $83.5M | $85.9M |
| FY2019 | $0 | $114.9M | $119.8M |
| FY2020 | — | $143.1M | $72.3M |
| FY2021 | — | $112.6M | $114.1M |
| FY2022 | — | $66.3M | $7.6M |